Ronald Castelino | Nephrology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Ronald Castelino | Nephrology | Best Researcher Award

Head of Pharmacy Practice, University of Sydney, Australia

Ronald L. Castelino, BPharm, MPharm, PhD, PDCR, MSHPA, is an Associate Professor in Pharmacology & Clinical Pharmacy at the University of Sydney and an Adjunct Senior Lecturer at the University of Tasmania. With a strong academic foundation and global experience in clinical pharmacy, especially nephrology, he focuses on the quality use of medicines in chronic diseases. His academic journey spans India and Australia, backed by leadership in teaching and translational research. He contributes extensively to nursing and pharmacy education while holding an active pharmacist role at Blacktown Hospital. Dr. Castelino has co-supervised multiple postgraduate research projects, published over 90 papers, and leads a research group focused on kidney disease management and medication safety. He is Board Certified in Geriatric Pharmacy and a Fellow of the Australia and New Zealand College of Advanced Pharmacy. A passionate educator, clinician, and researcher, he embodies a multidisciplinary approach to advancing pharmacy practice and patient-centered care.

Profile

🎓 Education

Dr. Ronald Castelino holds a PhD in Pharmacy Practice from the University of Sydney (2011), an MPharm in Pharmacy Practice (2006), and a BPharm (2003) from Rajiv Gandhi University of Health Sciences, Bangalore, India. He also completed a Professional Diploma in Clinical Research (PDCR, 2006) and is Board Certified in Geriatric Pharmacy (BCGP, 2018). In 2024, he was honored as a Fellow of the Australia and New Zealand College of Advanced Pharmacy (FANZCAP) for his contributions to nephrology and research. His educational achievements are distinguished with high academic honors, including a Gold Medal and Second Rank in his MPharm degree. This diverse educational background underpins his extensive work in clinical pharmacology, research methodology, and teaching. His academic preparation reflects a balance of clinical training, research competence, and leadership in the pharmaceutical sciences. These qualifications have enabled him to impact pharmacy education and practice across undergraduate, postgraduate, and professional levels.

🧪 Experience

Dr. Castelino has held progressive academic and clinical roles across India and Australia. He is currently Associate Professor at the University of Sydney (since 2023) and previously served as Senior Lecturer (2016–2022) and Lecturer at the University of Tasmania (2011–2016). His clinical experience includes roles as Renal Pharmacist at Blacktown Hospital (NSW, since 2016), Pharmacist at Calvary Health Care Tasmania (2012–2015), Clinical Educator at Royal Hobart Hospital, and Clinical Pharmacist in India (2004–2007). He has tutored at the University of Sydney (2008–2011) and coordinated various undergraduate and postgraduate subjects in pharmacy and nursing, including pharmacology, therapeutics, and evidence-based practice. Dr. Castelino has also served on scientific committees and has been instrumental in supervising PhD and MPhil candidates. His dual expertise in clinical pharmacy and academia supports a translational approach to patient care and education, positioning him as a bridge between hospital practice and academic advancement in medication safety and chronic disease management.

🏅 Awards and Honors

Dr. Ronald Castelino has received numerous accolades throughout his academic and professional career. He was awarded the Teaching Merit Certificate by the University of Tasmania in both 2013 and 2014 for excellence in education. His outstanding academic performance was recognized with the Second Rank in MPharm (Pharmacy Practice) by Rajiv Gandhi University of Health Sciences, Bangalore, India (2006). He was also the Gold Medallist and Best Outgoing Student at JSS College of Pharmacy, Mysore (2004–2005). In recognition of his expertise and leadership in nephrology and pharmacy research, he became a Fellow of the Australia and New Zealand College of Advanced Pharmacy (FANZCAP) in 2024. These awards underscore his commitment to advancing pharmacy practice, medical education, and health services research. His consistent recognition reflects both academic excellence and sustained contributions to pharmacy education, making him a highly respected educator and clinician in his field.

🔬 Research Focus

Dr. Castelino’s research centers on the quality use of medicines and chronic disease state management, particularly in kidney diseases. He leads a multidisciplinary research group at the University of Sydney dedicated to medication safety and health service improvement in nephrology. His translational research aligns with the University’s theme of “Better Health” and includes pharmacist-led medication review clinics, studies on metformin use in diabetes, and adverse drug reactions in elderly patients. He has supervised several PhD and MPhil students, with projects targeting medication regimen complexity in end-stage kidney disease and healthcare delivery models. Dr. Castelino’s work is informed by his clinical practice as a renal pharmacist and aims to bridge gaps between patient care and policy implementation. With over 97 publications, including book chapters and professional articles, his research has influenced both academic and hospital-based pharmacy practices. His focus remains on evidence-based interventions that enhance safety and outcomes in vulnerable populations.

✅ Conclusion

Dr. Ronald Castelino exemplifies the integration of academic excellence, clinical expertise, and research leadership in pharmacy practice. Through his commitment to improving medication safety and chronic disease management, he bridges gaps between education, research, and patient care. His contributions continue to shape pharmacy education and nephrology research in Australia and beyond.

 

Publications

Yi Zhang | Obesity and Inhibitory-control | Best Researcher Award

Posted on by sciencefather

Dr. Yi Zhang | Obesity and inhibitory-control | Best Researcher Award

Professor, Xidian University, China

Dr. Yi Zhang is a distinguished neuroscientist and professor at the School of Life Science and Technology, Xidian University, China, where he also directs the Center for Brain Imaging. Born in Xi’an, Shaanxi, China, in 1980, Dr. Zhang has dedicated his academic and research career to exploring the brain’s mechanisms using advanced neuroimaging tools. With a PhD in Pattern Recognition and Intelligent Systems, he combines engineering and neuroscience to investigate conditions like obesity, addiction, and acupuncture effects. He has published over 80 journal articles and served on editorial boards of several high-impact journals. His work emphasizes functional MRI, brain modulation, and neurofeedback to improve cognitive and behavioral health. Recognized with multiple national awards, Dr. Zhang has also served as a visiting scholar in the U.S. and holds memberships in prestigious global neuroscience and medical imaging societies. His research continues to drive innovation in non-invasive brain intervention and signal processing techniques.

Profile

🎓 Education

Dr. Yi Zhang’s academic journey is rooted in Xidian University, Xi’an, China, where he earned his Bachelor’s degree in Electronic Engineering in 2003. He continued his postgraduate studies in the same institution, receiving his Master’s degree in 2006 and PhD in 2009 in Pattern Recognition and Intelligent Systems, focusing on integrating engineering and intelligent control with neural research. His passion for bridging technology and life sciences led him to further his academic exposure abroad. From 2010 to 2011, he was a visiting scholar at the Department of Psychiatry and McKnight Brain Institute at the University of Florida College of Medicine in the United States. This international experience broadened his expertise in functional MRI and advanced medical imaging. His multidisciplinary educational background has laid a strong foundation for his research in brain imaging, signal processing, and behavioral neuroscience, allowing him to contribute significantly to understanding neural mechanisms in health and disease.

🧪 Experience

Dr. Yi Zhang has had a progressive academic career at Xidian University, starting as a Teaching Assistant in the School of Electronic Engineering (2006–2008), followed by roles as Lecturer (2008–2010), Associate Professor (2010–2015), and Professor since 2015 at the School of Life Science and Technology. His teaching has been complemented by his leadership as Director of the Center for Brain Imaging, where he spearheads interdisciplinary research projects. He has collaborated internationally as a visiting scholar at the University of Florida, enhancing his global perspective in brain imaging. His professional contributions encompass mentoring, publishing, and developing cutting-edge research on obesity, addiction, acupuncture, and real-time neurofeedback. Dr. Zhang has also held key editorial and organizational roles, showcasing his dedication to academic excellence. With over 15 years of continuous experience, he remains a prominent figure in neuroimaging, blending teaching and research to cultivate innovation in neuroscience and intelligent systems.

🏅 Awards and Honors

Dr. Yi Zhang has been the recipient of several prestigious national and institutional honors in recognition of his contributions to neuroscience and medical imaging. In 2022, he received the First Prize of the Shaanxi Higher Education Science and Technology Award for his research on brain modulation in obese patients. His work on acupuncture mechanisms using fMRI earned him First and Second Prizes from the China Society for Stereo Vision and Beijing Natural Science Award in 2015 and 2014, respectively. He was named an Early Career Investigator under the “Hua Mountain Scholar Program” in 2014 and by NIDA’s mini-convention in 2011. Additional accolades include First Prizes from the Shaanxi Higher Education and second prize from the Provincial Science and Technology Award in 2011. These recognitions affirm his innovative work in functional neuroimaging and its applications in cognitive enhancement, pain management, and behavioral intervention. His research continues to garner attention and impact across disciplines.

🔬 Research Focus

Dr. Yi Zhang’s research lies at the intersection of brain science, medical imaging, and behavioral neuroscience. His primary focus is the application of functional Magnetic Resonance Imaging (fMRI) to investigate brain activity in conditions like obesity, heroin addiction, and acupuncture. As Director of the Center for Brain Imaging, he leads studies on real-time neurofeedback to modulate brain functions, especially appetite and reward mechanisms. His work aims to decode neural patterns and develop interventions that influence behavior and cognition. With an engineering background, he also develops advanced signal processing algorithms to handle dynamic, multivariate neurobiological data. His interdisciplinary approach has helped bridge neuroscience and intelligent systems, enabling novel therapeutic strategies. Dr. Zhang’s research has influenced fields like psychopharmacology, neurofeedback therapy, and brain modulation, providing insights into the biological basis of behavior and supporting non-invasive treatment strategies. He has co-authored over 80 journal papers, affirming his position as a leader in neuroimaging innovation.

✅ Conclusion

Dr. Yi Zhang stands out as a visionary neuroscientist whose interdisciplinary expertise in engineering and life sciences advances brain imaging and cognitive neuroscience. Through pioneering research in fMRI, neurofeedback, and brain modulation, he addresses critical health issues like obesity, addiction, and pain. With a distinguished academic record, numerous awards, and a global scholarly presence, Dr. Zhang continues to shape the future of neuroscience research and education through his leadership, innovation, and dedication to improving human health.

Publications

  • A hybrid network integrating convolution and transformer for thymoma segmentation

    Intelligent Medicine
    2023-08 | Journal article
    DOI: 10.1016/j.imed.2022.06.003
    CONTRIBUTORS: Jingyuan Li; Wenfang Sun; Xiulong Feng; Karen M. von Deneen; Wen Wang; Guangbin Cui; Yi Zhang

  • MG-Net: Multi-level global-aware network for thymoma segmentation

    Computers in Biology and Medicine
    2023-03 | Journal article
    DOI: 10.1016/j.compbiomed.2023.106635
    CONTRIBUTORS: Jingyuan Li; Wenfang Sun; Karen M. von Deneen; Xiao Fan; Gang An; Guangbin Cui; Yi Zhang

  • Electroacupuncture enhances resting-state functional connectivity between dorsal caudate and precuneus and decreases associated leptin levels in overweight/obese subjects

    Brain Imaging and Behavior
    2022-02 | Journal article
    DOI: 10.1007/s11682-021-00519-3
    CONTRIBUTORS: Yang He; Karen M. von Deneen; Guanya Li; Borong Jing; Yanyan Zhou; Kaiya Zhang; Yi Zhang; Yuanyuan

  • A dense connection encoding–decoding convolutional neural network structure for semantic segmentation of thymoma

    Neurocomputing
    2021-09 | Journal article
    DOI: 10.1016/j.neucom.2021.04.023
    CONTRIBUTORS: Jingyuan Li; Wenfang Sun; Xiulong Feng; Gang Xing; Karen M. von Deneen; Wen Wang; Yi Zhang; Guangbin Cui

Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Posted on by sciencefather

Dr. Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Leeds Teaching Hospitals Trust, United Kingdom

Dr. Randeni A. Adithi H. Randeni is a Foundation Year One doctor at Leeds Teaching Hospital Trust with a dynamic portfolio in clinical research, innovation, and academic leadership. A graduate of the University of Leeds (MBChB), she has gained international exposure through observerships and research collaborations in the UK and USA, including SUNY Upstate. Her scholarly contributions span neurosurgery, cerebrospinal fluid dynamics, and biomedical innovation, with publications in top-tier journals such as IJMS, BJS, and BMC Medical Education. Dr. Randeni has received numerous awards and bursaries and is an active educator and mentor. Her leadership roles in university bodies and national societies reflect her commitment to academic excellence and inclusivity. With a future goal of specializing in neurosurgery, she aims to contribute to translational research and advance surgical practice globally through innovation and collaboration.

Profile

🎓 Education

Dr. Adithi Randeni earned her Bachelor of Medicine and Bachelor of Surgery (MBChB) from the University of Leeds, where she excelled in both academic and research endeavors. Her education was enriched by multiple research projects and electives across the UK and internationally, including SUNY Upstate Medical University in the USA. During her time at Leeds, she engaged deeply with translational research, contributing to projects on hydrocephalus, tissue engineering, neurotrauma, and breast cancer genetics. Her academic training included structured research programs and specialized modules in biomedical innovation, CSF dynamics, and advanced surgical techniques. She also undertook audits, systematic reviews, and service evaluations during clinical placements. Beyond formal education, she participated in national research fellowships and student interest groups that fostered interdisciplinary learning and mentorship. Dr. Randeni’s educational journey reflects a strong integration of clinical knowledge with scientific inquiry, preparing her for a future as a research-driven neurosurgeon and academic leader.

🧪 Experience

Dr. Adithi Randeni currently serves as a Foundation Year One doctor at Leeds Teaching Hospital Trust, where she is engaged in hands-on patient care, audits, and quality improvement projects. She has amassed extensive research experience through clinical, translational, and lab-based projects, including those at SUNY Upstate and the University of Leeds. Her past roles include conducting systematic reviews, performing service evaluations in neurosurgery, and leading national student surveys like SMART. She has presented her findings at both national and international conferences and has co-authored peer-reviewed articles and a book chapter. In addition to clinical duties, she has held leadership roles in student organizations, served as a medical student representative, and organized educational workshops. Her involvement with professional societies and interdisciplinary teams highlights her ability to balance clinical work, academic productivity, and collaborative initiatives, making her a well-rounded early-career professional with a clear trajectory in neurosurgical research and innovation.

🏅 Awards and Honors

Dr. Adithi Randeni has been the recipient of numerous academic awards, conference bursaries, and leadership recognitions during her medical training. Her achievements include international presentation opportunities and publication accolades for research on hydrocephalus, surgical outcomes, and student engagement in research pathways. She was invited to co-author a chapter in Springer’s “Arachnoid Cysts: State-of-the-Art” and has contributed to high-impact journals like the British Journal of Surgery and BMC Medical Education. She has earned research travel grants, elective placement scholarships, and teaching recognitions for organizing peer education workshops. Active in student leadership, she received commendations for her roles within the Medical Student Representative Council and societies such as NANSIG and the National MedTech Foundation. Her selection for the “Best Researcher Award” nomination reflects her growing influence in academic medicine. These honors affirm her commitment to excellence in research, innovation, and medical education at an early stage of her professional journey.

🔬 Research Focus

Dr. Adithi Randeni’s research focus lies at the intersection of neurosurgery, cerebrospinal fluid (CSF) dynamics, and biomedical innovation. She has explored pathological mechanisms such as abnormal transcytosis in hydrocephalus, authored a chapter on the genetics of arachnoid cysts, and is actively investigating CSF composition in hydrocephalus through collaborations with SUNY Upstate. Her research interests also include neurotrauma, surgical outcomes, antimicrobial stewardship, and tissue-engineered cardiovascular grafts. With a strong inclination toward translational research, she integrates clinical insights with lab-based findings to drive innovation. Dr. Randeni also explores medical education, having co-led the SMART study on student engagement in research. Her contributions aim to bridge the gap between bedside care and bench science, with ongoing work assessing surgical site infections and diagnostic accuracy in neurosurgical imaging. She is passionate about leveraging biomedical research and digital tools to enhance patient outcomes and surgical practice, particularly in underserved and complex neurological conditions.

✅ Conclusion

Dr. Adithi Randeni exemplifies the fusion of clinical excellence, research innovation, and educational leadership, positioning her as a promising future leader in neurosurgery and translational science.

Publications

  • Abnormal Transcytosis Mechanisms in the Pathogenesis of Hydrocephalus: A Review

    International Journal of Molecular Sciences
    2025-05-19 | Journal article
    DOI: 10.3390/ijms26104881
    Part ofISSN: 1422-0067
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurthy

  • Genetics of Arachnoid Cysts

    Arachnoid Cysts
    2023 | Book chapter
    DOI: 10.1007/978-3-031-22701-1_8
    Part ofISBN: 9783031227004
    Part ofISBN: 9783031227011
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurth

  • Cross-sectional Survey of Medical student perceptions of And desires for Research and Training pathways (SMART): an analysis of prospective cohort study of UK medical students

    BMC Medical Education
    2023-12-15 | Journal article
    DOI: 10.1186/s12909-023-04881-2
    Part of ISSN: 1472-6920
    CONTRIBUTORS: Gokul Parameswaran; Amelia Bowman; Catherine Swales; Setthasorn Zhi Yang Ooi; Shie Wei Chan; Priya Rose Babu; Daniele Ramsay; Sofia Kostoudi; Soham Bandyopadhyay; SMART-NANSIG-InCiSion Collaborative et al.

Timea Claudia Ghitea | Metabolic Syndrome | Women Researcher Award

Posted on by sciencefather

Dr. Timea Claudia Ghitea | Metabolic Syndrome | Women Researcher Award

Universitary Assistant, University of Oradea, Romania

GHITEA TIMEA-CLAUDIA is a Romanian expert in pharmacy and clinical nutrition, with over two decades of professional experience combining pharmaceutical practice, clinical and sports nutrition, and academic teaching. She currently serves as a university assistant at the Faculty of Medicine and Pharmacy in Oradea and leads nutrition initiatives at Echo Laboratories. Her career began in 1999 as a pharmacy assistant, advancing through key leadership roles, including pharmacist director in various pharmacies. Holding dual specialization in pharmacy and biomedical sciences, Dr. Ghitea completed her doctorate in Clinical and Sports Nutrition in 2020. A multilingual professional, she is committed to interdisciplinary collaboration and student mentorship. Her dynamic profile is strengthened by memberships in national and international professional societies. She also contributes actively to administrative roles in academic and pharmaceutical organizations. Dr. Ghitea is a respected voice in the evolving field of clinical nutrition and personalized healthcare in Romania.

Profile

🎓 Education

GHITEA TIMEA-CLAUDIA holds a robust academic portfolio encompassing both pharmaceutical and biomedical disciplines. She earned her Doctorate in Biomedical Sciences with a focus on Clinical and Sports Nutrition in 2020 and completed postgraduate studies in Nutrition and Dietetics in 2017. Her foundational studies include a Master’s degree in Cell Biology (2006), a Pharmacy degree from the Faculty of Medicine and Pharmacy in Oradea (2006), and a Bachelor of Science in Biology-Chemistry (2002). She also holds a diploma as a Pharmacy Assistant from the Vasile Voiculescu Post-High School (1999) and graduated high school from Ady Endre Theoretical High School in 1997. She has continuously enhanced her expertise through specializations such as a residency in Clinical Pharmacy (2009) and various professional training programs. Her academic involvement is complemented by her roles in professional boards and committees, contributing significantly to pharmacy and nutrition education in Romania.

🧪 Experience

GHITEA TIMEA-CLAUDIA brings more than 25 years of hands-on experience in pharmacy, healthcare, and academia. Since 2017, she has served as a university assistant at the Faculty of Medicine and Pharmacy, Oradea, while also leading clinical and sports nutrition services at Echo Laboratories. Previously, she was pharmacist director at Serbien Pharmacy (2012–2017) and MIG3 Pharmacy (2011–2012). Her career began as a pharmacy assistant at Delia Pharmacy (1999–2006), followed by a pharmacist role at Fontana Pharmacy (2006–2011). A proactive mentor and project leader, she supervises internships and facilitates interdisciplinary collaboration to address complex patient cases in nutrition. Her leadership extends to project management and service coordination in clinical nutrition. Her deep understanding of pharmacy and dietetics, combined with strong communication, organizational, and mentoring skills, ensures her consistent contribution to healthcare innovation and medical education. She effectively bridges academic knowledge with clinical application and professional governance.

🏅 Awards and Honors

GHITEA TIMEA-CLAUDIA has earned recognition through key leadership roles and active participation in prominent professional associations. She was appointed President of the Discipline Committee at the College of Pharmacists, Bihor, in 2011, and later served as a member of both the General Assembly and the Discipline Committee. Her involvement spans national and international professional societies, including the American Society for Nutrition (2017), the Romanian Society of Pharmaceutical Sciences (2019), and the Pharmacological Association of Romania (since 2006). She is also a member of the Nutritionists Association of Romania (2022) and the Society of Pharmaceutical History Romania (2019). Her consistent efforts in academic mentorship earned her the role of Internship Mentor, and she was designated Project Manager in 2022. These accolades underscore her leadership, dedication to advancing pharmacy and nutrition sciences, and her commitment to mentoring future professionals. Her honors reflect a sustained contribution to both clinical practice and scholarly engagement.

🔬 Research Focus

Dr. GHITEA TIMEA-CLAUDIA’s research focus lies at the intersection of clinical pharmacy, sports nutrition, and biomedical science. Her work is dedicated to optimizing patient care through evidence-based nutritional strategies and the integration of pharmaceutical knowledge into personalized dietetic plans. Her doctoral studies in Clinical and Sports Nutrition laid the foundation for a research trajectory that includes metabolic optimization, nutritional therapy in chronic diseases, and the role of diet in athletic performance and recovery. She actively collaborates with international colleagues to solve complex clinical nutrition cases and contributes to interdisciplinary projects aimed at enhancing nutritional interventions. As a university assistant and project leader, she mentors students in clinical research methodology, practical case-solving, and the application of nutritional science in medical contexts. Her expertise is instrumental in bridging academic insights with real-world patient outcomes, promoting innovation in clinical nutrition and pharmacy-driven healthcare models.

✅ Conclusion

Dr. Ghitea Timea-Claudia is a dynamic healthcare professional whose career seamlessly bridges pharmaceutical science, clinical nutrition, and academic leadership. Her vast experience, ongoing research, and dedication to student mentorship reflect her holistic and forward-thinking approach to health education and patient care.

Publications

  • Vaccine Adherence: From Vaccine Hesitancy to Actual Vaccination and Reasons for Refusal of Childhood Vaccines in a Group of Postpartum Mothers

    In Vivo
    2025 | Journal article
    DOI: 10.21873/INVIVO.13855
    WOSUID: WOS:001391824800006
    CONTRIBUTORS: Iova, Camelia florina; Daina, Lucia georgeta; Ilea, Codrin dan nicolae; Domnariu, Horatiu Paul; Ghitea, Timea claudia; Daina, Madalina Diana Daina

  • The Impact of Thrombophilia on Maternal and Neonatal Outcomes: A Multisystem Analysis of Clinical, Hematological, and Metabolic Parameters

    Journal of Clinical Medicine
    2025-05-23 | Journal article
    DOI: 10.3390/jcm14113665
    CONTRIBUTORS: Viorela-Romina Murvai; Radu Galiș; Cristina-Maria Macrea; Anca-Florina Tărău-Copos; Marius Daniel Goman; Timea Claudia Ghitea; Anca Huniadi

  • Stomatognathic Dysfunction and Neuropsychological Imbalance: Associations with Salivary Cortisol, EMG Activity, and Emotional Distress

    Dentistry Journal
    2025-05-22 | Journal article
    DOI: 10.3390/dj13060230
    CONTRIBUTORS: Ioana Scrobota; Liliana Sachelarie; Timea Claudia Ghitea; Georgiana Ioana Potra Cicalau; Roxana Alexandra Cristea; Pelea Diana; Petra Saitos; Alexandra Vlad; Loredana Liliana Hurju

  • Correlation Between Vitamin D Deficiency (25(OH)D3) and the Severity of Purulent Oropharyngeal Infections

    Journal of Clinical Medicine
    2025-04-01 | Journal article
    DOI: 10.3390/jcm14072410
    CONTRIBUTORS: Florian Ciprian Venter; Timea Claudia Ghitea; Adrian Nicolae Venter; Amin-Florin El-kharoubi; Mousa El-kharoubi; Evelin Claudia Ghitea; Marc Cristian Ghitea; Amina Vente

  • Psychological Distress and Quality of Life in Patients with Colon Cancer: Predictors, Moderating Effects, and Longitudinal Impact

    Healthcare
    2025-03-27 | Journal article
    DOI: 10.3390/healthcare13070753
    CONTRIBUTORS: Lavinia Alina Rat; Timea Claudia Ghitea; Adrian Marius Maghiar

Habibullah Eatamadi | Thyroid eye disease | Best Researcher Award

Posted on by sciencefather

Dr. Habibullah Eatamadi | Thyroid eye disease | Best Researcher Award

Consultant Oculoplastic Surgeon, Sheikh Shakhbout Medical City, United Arab Emirates

Dr. Habibullah Eatamadi is a distinguished Consultant Oculoplastics, Lacrimal, and Orbital Surgeon with extensive experience in both clinical practice and academic leadership. Born on February 3, 1968, he holds Irish nationality and is registered with multiple medical councils, including the UAE DOH and the UK GMC. He has served in leading ophthalmic institutions across the UK and UAE, such as Sheikh Shakhbout Medical City and Sheikh Khalifa Medical City. His fellowships in Oculoplastics and Pediatric Ophthalmology from top UK hospitals have shaped his expertise in complex surgeries. He is a member of prestigious societies like ASOPRS, BOPSS, and the AAO. Known for his compassionate care and dedication to innovation, Dr. Eatamadi is actively involved in teaching, clinical audits, and presenting at global conferences. His leadership in ophthalmology has had a transformative impact on eye care services in the UAE.

Profile

🎓 Education

Dr. Eatamadi completed his MD from Albert Szent Gyorgyi Medical University, Szeged, Hungary, in 1993. His postgraduate education includes a specialty degree in Ophthalmology from Haynal Imre Postgraduate Medical University, Budapest, in 1997, followed by the FRCS in Ophthalmology from the Royal College of Surgeons, Edinburgh, in 1999. To complement his clinical expertise with administrative acumen, he pursued a Master’s degree in Healthcare Management from Zayed University in collaboration with North Carolina University in 2014. His education reflects a well-rounded foundation in both medical science and healthcare leadership. He holds full registrations with the Irish Medical Council (IMC), UK General Medical Council (GMC), and the UAE Department of Health. Dr. Eatamadi’s continuous pursuit of knowledge through fellowships and academic programs has been pivotal in shaping his subspecialty focus on Oculoplastics, Lacrimal, and Orbital Surgery. His academic background demonstrates both depth and breadth in clinical medicine and healthcare systems.

🧪 Experience

Dr. Habibullah Eatamadi has over two decades of international clinical experience in ophthalmology, particularly in Oculoplastics, Lacrimal, and Orbital Surgery. He currently serves as Consultant Ophthalmic Surgeon at Sheikh Shakhbout Medical City, UAE, since December 2020. Previously, he was Head of the Department at Sheikh Khalifa Medical City (2011–2020) and Consultant at Tawam Hospital (2008–2011). His fellowship training across top UK hospitals, including the Western Eye Hospital and University Hospital Nottingham, has provided a strong foundation in subspecialties like pediatric ophthalmology, endolacrimal, and orbital surgery. He has also worked at Leicester Royal Teaching Hospital as a locum ophthalmologist. In addition to clinical duties, Dr. Eatamadi was the Ophthalmology Residency Program Director (2011–2016) and continues to serve as Associate Program Director. His teaching, audit, and surgical experience have made him a key contributor to the evolution of ophthalmic practice in the UAE and beyond.

🏅 Awards and Honors

Dr. Eatamadi has been recognized for his surgical outcomes, academic leadership, and commitment to excellence in ophthalmology. His internal audits, including the conjunctival ptosis surgery audit at SKMC (2017–2020), achieved a 92% success rate with minimal complications and was subsequently published, reflecting his commitment to clinical quality and evidence-based care. Another notable achievement was his audit on external DCR at Tawam Hospital (2009–2010), where he demonstrated a 95% success rate, aligning with global standards. He is regularly invited to present at international conferences such as the British Oculoplastic Surgery Society and the Emirates Thyroid Congress, where his recent work on thyroid eye disease and biologic treatments has gained regional recognition. As an active member of professional societies including ASOPRS and ITEDS, he contributes to knowledge dissemination and practice improvement. His honors stem from years of clinical excellence, educational mentorship, and innovation in oculoplastic and orbital surgery.

🔬 Research Focus

Dr. Eatamadi’s research interests focus on clinical outcomes and therapeutic advancements in oculoplastics, lacrimal, and orbital surgery. His work integrates surgical precision with modern therapeutic approaches, such as the use of biologics in thyroid eye disease, including Tocilizumab and Teprotumumab, which he presented at leading conferences in 2025. His research extends to outcome-based audits, such as his evaluation of DCR procedures and conjunctival ptosis repairs, reflecting his evidence-based approach to patient care. Additionally, his academic involvement includes curriculum development for ophthalmology residents, promoting research-driven education. Through case audits, clinical trials, and presentations, Dr. Eatamadi continues to shape the future of subspecialty ophthalmology in the UAE. He is particularly interested in enhancing surgical outcomes, reducing complications, and applying new biologics for complex orbital inflammatory conditions. His research focus supports his dual role as a clinician and educator, ensuring that scientific advances are translated into high-quality patient outcomes.

✅ Conclusion

Dr. Habibullah Eatamadi is a highly accomplished oculoplastic surgeon whose international training, extensive experience, academic contributions, and research innovations have significantly advanced ophthalmic care in the UAE and beyond.

Publications

  • Tocilizumab use for optic nerve compression in thyroid eye disease: a prospective longitudinal cohort

  • Eatamadi, H., AlMazrouiel, O., Al Qatan, N., Ibrahim, H., & Eatamadi, S. (2025). Teprotumumab use in Thyroid Eye Disease: Clinical Outcomes in the United Arab Emirates – A First Regional Case Series. Seminars in Ophthalmology. https://doi.org/10.1080/08820538.2025.2503911
  • Habroosh, F. A., Albrashdi, S. S., Alsaadi, A. H., Eatamadi, H. (2024). Tocilizumab Use for Optic Nerve Compression in Thyroid Eye Disease: A Prospective Longitudinal Cohort. International Ophthalmology, 44, 222. https://doi.org/10.1007/s10792-024-03143-4
  • Eatamadi, H., et al. (2024). Economic Burden Impact of Thyroid Eye Disease in the United Arab Emirates. Poster presented at ISPOR USA, May 2024, Atlanta, GA, USA.
  • Alalawi, F., Almazroui, O., Alsaadi, A., Eatamadi, H. (2023). Severe Dysthyroid Optic Neuropathy Following SARS-CoV-2 Vaccination Treated with Tocilizumab: First Two Reported Cases. Open Journal of Clinical & Medical Case Reports, 9(19).
  • Almazrouei, O., Alalawi, F., Albrashdi, S., Alsharqi, H., Alsaadi, A., Hammad, M., Sabri, A., Eatamadi, H. (2023). A 46-Year-Old Woman with a 4-Year History of Graves’ Disease, with Severe Corticosteroid-Unresponsive Thyroid Eye Disease, Successfully Treated with Tocilizumab. American Journal of Case Reports, 24, e938487. https://doi.org/10.12659/AJCR.938487

Ganesh Basawaraj Birajadar | EEG Signal Processing | Best Researcher Award

Posted on by sciencefather

Dr. Ganesh Basawaraj Birajadar | EEG Signal Processing | Best Researcher Award

Associate Professor| Fabtech Technical Campus College of Engineering & Research, Sangola

Dr. Birajadar Ganesh Basawaraj is an Associate Professor with over 12 years of academic and research experience, specializing in Machine Learning, Signal Processing, Biomedical AI, and Computer Vision. Currently serving as the Head of Department at Fabtech Technical Campus, Sangola, he holds a Ph.D. in Electrical & Electronics Engineering from VTU, where his research focused on brain abnormality detection using EEG signal analysis. Dr. Birajadar has published over 10 Scopus/SCI-indexed papers, guided numerous UG/PG projects, and reviewed international conferences (IEEE, Springer). With five patents filed in IoT and robotics and a copyright for a dermatological AI tool, he actively contributes to innovation in biomedical and AI domains. His academic journey and professional excellence reflect in his subject expertise, technical leadership, and student mentorship, making him a valuable contributor to engineering education and applied AI research.

Profile

🎓 Education

Dr. Birajadar earned his Ph.D. in Electrical & Electronics Engineering Sciences from PDACE Kalaburagi (VTU) in March 2024, focusing on AI-based EEG signal analysis for brain abnormality detection. He holds an M.E. in Signal Processing from SKNCOE, Pune University, where he ranked 7th with a CGPA of 7.45 in May 2012. He completed his B.E. in Electronics & Telecommunication from SVERI, Solapur University, with distinction in July 2009. His pre-university education includes H.S.C. (86.50%) from KBP College and S.S.C. (85.20%) from DHK Prashala, both under Pune Board. Dr. Birajadar’s education combines a strong theoretical foundation with hands-on expertise in electronics, signal processing, and AI applications, further strengthened by numerous certifications in Python, MATLAB, IoT, Machine Learning, and Data Science from prestigious platforms like NPTEL, Google, Infosys Springboard, and Coursera, shaping him into a well-rounded academic and research professional.

🧪 Experience

Dr. Birajadar currently serves as Associate Professor and Head of Department at Fabtech Technical Campus College of Engineering & Research, Sangola (from Jan 2025), and previously as Assistant Professor at the same institute (June–Dec 2024). Prior to that, he spent over a decade (2012–2024) as Assistant Professor at Smt. Kashibai Navale SCOE, Pandharpur, where he significantly contributed to teaching and research. He also worked as a Trainee Engineer at ITIE Knowledge Solutions, Bangalore. With over 12 years of academic experience, Dr. Birajadar has taught a wide range of subjects such as Machine Learning, Digital Signal Processing, MATLAB Simulink, Communication Buses, Image and Video Processing, and AI tools. He has delivered expert lectures at various institutions and led curriculum innovation. His strong command of tools like Python, MATLAB, TensorFlow, and LabVIEW complements his hands-on guidance of 18 UG and 2 PG projects in AI and biomedical domains.

🏅 Awards and Honors

Dr. Birajadar has received several prestigious awards and recognitions. He secured the 7th University Rank in M.E. (Signal Processing) from Pune University and received a Silver Medal in the NPTEL course “The Joy of Computing using Python.” He was awarded second prize in an AICTE-sponsored STTP Idea Competition and received a Letter of Appreciation from the Entrepreneurship Development Cell. He served as the Primary Evaluator in Toycathon 2021 and is a member of the National Institute for Technical Training & Skill Development. He is designated as a reviewer for “Inter Journal of Computing and Digital Systems (IJCDS)” (SCOPUS-indexed) and the “International Journal of Biomedical Engineering and Clinical Science” (2024–2027). Additionally, he has worked as a reviewer for several international conferences and contributed significantly to promoting innovation, technical evaluation, and academic excellence in AI, signal processing, and biomedical applications.

🔬 Research Focus

Dr. Birajadar’s research focuses on the intersection of Artificial Intelligence and Biomedical Engineering, particularly EEG signal analysis for brain abnormality detection. His work explores the use of AI/ML algorithms to interpret non-stationary biomedical signals, offering clinical insights into neurological disorders. He is deeply involved in Biomedical Signal and Image Processing, leveraging Machine Learning, Deep Learning, and Computer Vision techniques for healthcare innovation. He also explores the Internet of Things (IoT), Embedded Systems, and Big Data Analytics to develop smart, real-time solutions such as landmine detection robots, COVID care bots, and smart vending machines—many of which are patented. His contributions span across pattern recognition, signal feature extraction, and intelligent classification systems. Dr. Birajadar integrates academic rigor with practical application, aiming to enhance diagnostics, patient monitoring, and AI-based clinical tools. He has guided several projects and published extensively in indexed journals, cementing his role as a leading researcher in biomedical AI.

✅ Conclusion

Dr. Birajadar Ganesh Basawaraj is a dedicated academician, innovative researcher, and inspiring mentor, whose interdisciplinary expertise in AI, biomedical signal processing, and IoT drives impactful solutions in healthcare and engineering education.

Publications

Mohamed Amine Guerroudji | Brain cancer | Best Researcher Award

Posted on by sciencefather

Mr. Mohamed Amine Guerroudji | Brain cancer | Best Researcher Award

Research Scholar|CENTER FOR DEVELOPMENT OF ADVANCED TECHNOLOGIES (CDTA), Algeria

ohamed Amine Guerroudji, né le 29 mai 1987 à Blida, Algérie, est un docteur en électronique spécialisé dans le traitement d’images médicales, en particulier la détection automatisée des micro-calcifications dans les mammographies. Il exerce depuis 2015 en tant que professeur de mathématiques au cycle moyen et a assuré plusieurs missions d’enseignement vacataire à l’Université de Blida, dans les domaines de la programmation en C, du MATLAB, des méthodes numériques, et de l’électronique générale. Passionné par la recherche appliquée, il a publié dans des conférences et revues internationales, notamment sur l’amélioration du contraste et la segmentation des images médicales. Il est également membre actif des comités scientifiques de conférences internationales en photonique et optique. Polyglotte (arabe, français, anglais), il combine rigueur scientifique, esprit d’équipe et adaptabilité dans ses missions pédagogiques et de recherche.

Profile

🎓 Education

Mohamed Amine Guerroudji a obtenu son doctorat en électronique en avril 2017 à l’Université Mouloud Mammeri de Tizi-Ouzou avec mention très honorable, avec une recherche axée sur la segmentation des images mammographiques pour détecter les micro-calcifications. Il détient un Master en électronique (traitement de l’information et systèmes électroniques) obtenu en 2013 à l’Université Saad Dahlab de Blida, avec un mémoire en imagerie médicale noté Très Bien. Sa licence en génie électronique (option réseaux et télécommunications) a été obtenue en 2011 à la même université. Il est également titulaire d’un baccalauréat technique en fabrication mécanique (2007), d’une formation en premiers secours (Croissant Rouge Algérien, 2010), et a suivi une formation sur l’usage des bases de données scientifiques (Web of Science, 2014). Son parcours académique illustre un engagement profond envers l’innovation technologique et la recherche appliquée en électronique médicale.

🧪 Experience

Depuis 2015, Mohamed Amine Guerroudji enseigne les mathématiques au cycle moyen en Algérie. Parallèlement, il a été enseignant vacataire à l’Université de Blida entre 2013 et 2018, intervenant dans des modules tels que TP Langage C, TP Méthodes Numériques, TP MATLAB, Outils de Programmation Mathématique et Électronique générale. Il a également dispensé des cours d’électricité générale et d’électronique dans un institut spécialisé en arts graphiques. Son expérience diversifiée dans l’enseignement supérieur et secondaire reflète sa capacité à s’adapter à différents publics et niveaux d’apprentissage. Il combine son savoir technique avec une approche pédagogique pratique, en mettant l’accent sur la programmation appliquée et la modélisation mathématique. Son expertise couvre également l’utilisation de logiciels comme MATLAB, Workbench, VHDL et C++, renforçant sa polyvalence dans le domaine de l’électronique appliquée.

🏅 Awards and Honors

Mohamed Amine Guerroudji a reçu plusieurs distinctions académiques, notamment la mention Très Honorable pour sa thèse de doctorat en électronique en 2017 et la mention Très Bien pour son mémoire de master en imagerie médicale. Il est reconnu au niveau international pour ses contributions scientifiques dans le domaine du traitement d’images médicales, avec des publications dans des conférences de renom telles que ISPA 2017, ICESTI 2016 et des revues comme Optik – International Journal for Light and Electron Optics. Il a également été sélectionné comme membre du comité scientifique de conférences prestigieuses sur l’optique et la photonique : OPAL 2018 (Barcelone) et OPAL 2019 (Amsterdam). Ces reconnaissances soulignent la qualité et l’impact de ses travaux de recherche, ainsi que son implication dans la communauté scientifique internationale.

🔬 Research Focus

Mohamed Amine Guerroudji concentre sa recherche sur le traitement d’images médicales, plus précisément sur la détection automatique des micro-calcifications mammaires à partir de clichés mammographiques. Son travail de doctorat portait sur la segmentation d’images pour l’aide au diagnostic précoce du cancer du sein, en utilisant des algorithmes comme les contours actifs (géometric deformable models), les transformations morphologiques (white Top-Hat) et la méthode de seuillage d’Otsu. Il a proposé de nouvelles approches d’amélioration de contraste dans les mammographies, visant à rendre les foyers pathologiques plus visibles pour les praticiens. Ses recherches intègrent des techniques avancées de traitement numérique, associant la programmation MATLAB à l’analyse morphométrique. À travers ses publications, il cherche à améliorer la précision et l’automatisation dans les systèmes d’aide à la décision médicale, tout en explorant l’intersection entre l’électronique, la médecine et l’intelligence artificielle.

✅ Conclusion

Mohamed Amine Guerroudji est un expert algérien en électronique et traitement d’images médicales, combinant expérience pédagogique, excellence académique et innovation scientifique au service de la santé et de l’éducation.

Publications

Busra Buran | Decision Making | Best Researcher Award

Posted on by sciencefather

Dr. Busra Buran | Decision Making | Best Researcher Award

Research Scholar| Istanbul Technical University, Turkey

Dr. Büşra Buran, born on August 13, 1988, in Kocaeli, Turkey, is a prominent expert in management engineering with a career deeply rooted in public transportation strategy and optimization. She currently serves as the Head of Strategy Development at IETT, Istanbul’s public transport authority. With over a decade of professional experience, Dr. Buran has successfully led numerous projects involving strategic planning, quality management, service improvement, and international collaboration. Her academic achievements include a Ph.D. in Management Engineering from Istanbul Technical University, an M.Sc. in Industrial Engineering from Galatasaray University, and a B.Eng. in Industrial Engineering from Yıldız Technical University. Fluent in English, she combines technical expertise with leadership capabilities, supported by various certifications in project management, quality control, and innovation. Her work has been recognized internationally, and she actively contributes to research with several publications focusing on fuzzy logic applications, transportation models, and digital transformation strategies in public transit systems.

Profile

🎓 Education

Dr. Büşra Buran holds a robust academic background in industrial and management engineering. She completed her Ph.D. in Business Management Engineering at Istanbul Technical University (2018–2023), graduating with a GPA of 3.5/4. Her doctoral research focused on advanced decision-making methods and innovation in public transportation. Prior to that, she earned her Master of Science in Industrial Engineering from Galatasaray University (2010–2012), achieving a GPA of 3.5/4. She began her academic journey with a Bachelor’s degree in Industrial Engineering from Yıldız Technical University (2007–2010), graduating with distinction (3.4/4). Her academic excellence is complemented by certifications in project management, innovation, quality systems, and team leadership. Dr. Buran’s education is deeply integrated with applied engineering practices, statistical modeling (SPSS, Minitab), simulation tools (Simul8), and machine learning (R), equipping her with a strong foundation in both theory and practice. Her studies enabled her to apply analytical, technical, and managerial skills to large-scale public service systems.

🧪 Experience

Dr. Büşra Buran has extensive professional experience in the public transportation sector, primarily at IETT, Istanbul’s leading transit authority. Since 2017, she has been serving as the Head of Strategy Development, where she manages strategic planning, performance metrics, quality systems, corporate innovation, and international partnerships. From 2014 to 2017, she was the Manager of Service Improvement, leading the development of a service quality model, auditing standards, and benchmarking global practices. Between 2013 and 2014, she worked as the Manager of Operation Planning, handling performance analysis and optimization of bus networks, including collaborative projects with TÜBİTAK. Her career began in 2010 as a Consultant for Istanbul’s Bus Rapid Transit system, optimizing routes and managing training for international BRT implementations. She is experienced in project management, process auditing, KPI reporting, and digital transformation. Her leadership has significantly enhanced the efficiency and global standing of Istanbul’s public transport network.

🏅 Awards and Honors

Dr. Büşra Buran has consistently demonstrated academic and professional excellence throughout her career. She graduated with honors at every level—achieving GPAs of 3.4/4 in her undergraduate studies, 3.5/4 in her master’s, and 3.5/4 during her Ph.D. She has also been recognized for her contributions to transportation planning and quality improvement at IETT, receiving internal commendations for successful project outcomes and strategic innovations. Her scientific research on fuzzy logic applications in public transport and sentiment analysis during the COVID-19 pandemic has been published in prestigious journals and international conferences by Springer and Elsevier. She has also earned certifications in Project Management, Corporate Quality, Risk & Process Management, and Leadership Innovation, strengthening her credentials as a thought leader in urban mobility systems. Her scholarly achievements, combined with her impactful real-world projects, highlight her as a distinguished figure in engineering management and urban transportation.

🔬 Research Focus

Dr. Buran’s research centers on the intersection of engineering management, public transportation systems, and fuzzy decision-making models. Her Ph.D. work and subsequent publications explore advanced methodologies such as Spherical and Intuitionistic Fuzzy AHP, hybrid fuzzy systems, sentiment analysis, and business model frameworks tailored for urban transport. She has published widely on topics such as bus type selection, public transport quality modeling, and global benchmarking of transit business models. Her studies frequently employ machine learning and simulation tools like R and Simul8, along with statistical software for system optimization. A significant part of her work also delves into digital transformation, strategic innovation, and service efficiency in public bus systems, particularly in mega-cities like Istanbul. Her research not only contributes theoretical advancements in engineering management but also provides practical insights for decision-makers in transit agencies, enhancing transportation planning, passenger satisfaction, and sustainable mobility strategies.

✅ Conclusion

Dr. Büşra Buran exemplifies the synergy between academic research and public sector innovation. With her strong background in industrial and management engineering, she has driven strategic advancements in Istanbul’s public transportation. Her work is a testament to effective leadership, data-driven decision-making, and continuous quality improvement in urban mobility systems.

Publications

Ishrat Mahjabeen | Tumor Biomarkers | Best Scholar Award

Posted on by sciencefather

Dr. Ishrat Mahjabeen | Tumor Biomarkers | Best Scholar Award

Academician/Research Scholar |COMSATS University Islamabad, Pakistan

Dr. Ishrat Mahjabeen is an accomplished molecular biologist and cancer geneticist currently serving as Associate Professor at COMSATS University Islamabad, with extensive expertise in head and neck cancer, gene regulation, and microRNA biology. She earned her PhD in Cancer Genetics from COMSATS and recently completed a prestigious Fulbright Postdoctoral Fellowship at Brown University, USA. Dr. Mahjabeen has over two decades of research and academic experience, contributing significantly to molecular oncology through her work on base excision repair pathway genes, miRNA dysregulation, and genetic polymorphisms. She has also been an active educator, having supervised numerous undergraduate and graduate students and taught a variety of bioscience courses. Her scholarly contributions include a Springer book chapter and multiple international conference presentations. With a deep commitment to cancer research and academic mentorship, she continues to shape the future of biomedical science in Pakistan and beyond through her innovative work and international collaborations.

Profile

🎓 Education

Dr. Ishrat Mahjabeen holds a diverse academic background rooted in biological sciences. She earned her Postdoctoral Research Fellowship (2023–2024) from Brown University, USA, through the esteemed Fulbright Scholarship Program. Her PhD in Cancer Genetics was awarded by COMSATS Institute of Information Technology Islamabad in 2013, where she conducted a thesis on deregulated base excision repair pathway genes and microRNAs in head and neck cancer. Prior to her doctorate, she completed her M.Phil. in Developmental Biology from Quaid-e-Azam University in 2006, focusing on methylcobalamin’s role in sciatic nerve regeneration in rabbits. Her academic journey began with an MSc in Zoology from the University of Arid Agriculture Rawalpindi in 2003, where she explored the impact of temperature on arthropod populations. This strong foundation across developmental biology, zoology, and cancer genetics has equipped her with a multi-dimensional understanding of complex biological systems, enabling her significant contributions to cancer research and biosciences education.

🧪 Experience

Dr. Ishrat Mahjabeen has over 20 years of rich research and academic experience in biosciences and molecular oncology. Since May 2024, she has been serving as Associate Professor at COMSATS University Islamabad, where she previously held the positions of Assistant Professor (2017–2024) and Senior Scientific Officer (2014–2017). Her academic journey began with research fellowships at leading institutions, including the Center for Molecular Biology of Oral Diseases at the University of Illinois at Chicago, Quaid-e-Azam University, and PMAS Arid Agriculture University. She also contributed as an honorary lecturer in Talagang. As a committed educator, she has supervised over 140 students across BS, MS, and PhD levels and has taught advanced courses in molecular biology, research techniques, and biochemistry. Her leadership in academia is marked by dedication to translational cancer research, curriculum development, and capacity building in the life sciences, fostering innovation and scientific rigor among emerging researchers.

🏅 Awards and Honors

Dr. Ishrat Mahjabeen has been honored with the prestigious Fulbright Postdoctoral Research Fellowship (2023–2024) at Brown University, USA—an international recognition of her excellence in cancer genetics research. Her academic achievements and research impact have earned her continued faculty promotions within COMSATS University Islamabad, reflecting her contributions to teaching, student mentorship, and scientific leadership. She has received recognition for her work through invited talks and presentations at notable global scientific platforms, including the American Association of Extracellular Vesicles (AAEV 2023) in Boston and multiple international conferences in Turkey and Pakistan. Her chapter contribution in a Springer book on head and neck cancer highlights her thought leadership in molecular oncology. These accolades underscore her pioneering work in cancer biology, particularly in miRNA and gene regulation research, as well as her role in fostering academic excellence and collaborative innovation across borders.

🔬 Research Focus

Dr. Ishrat Mahjabeen’s research centers on molecular oncology with a focus on genetic and epigenetic mechanisms underlying cancer development, particularly head and neck cancers. Her PhD work explored deregulated base excision repair pathway genes and the role of microRNAs in tumor progression. She investigates how miRNA dysregulation, gene polymorphisms, and checkpoint kinase alterations contribute to tumorigenesis, with significant emphasis on gliomas, gastric cancer, and H. pylori-associated pathogenesis. Dr. Mahjabeen is also involved in studying exosomal miRNAs and their functional targets, aiming to identify biomarkers and therapeutic targets. Her translational research approach integrates molecular biology with bioinformatics to unravel cancer pathways and personalize treatment strategies. Her postdoctoral research at Brown University further broadened her scope, allowing global collaborations and access to advanced genomic tools. She remains committed to bridging basic research and clinical relevance to improve early cancer diagnostics and targeted therapies in low-resource healthcare settings.

✅ Conclusion

Dr. Ishrat Mahjabeen stands out as a dynamic academic and cancer researcher, combining excellence in teaching, mentorship, and cutting-edge molecular oncology. Her global exposure, leadership in translational research, and unwavering commitment to biosciences make her an asset to the scientific community.

4o
Publications

Do Gun Kim | Environmental Engineering | Best Researcher Award

Posted on by sciencefather

Prof Dr. Do Gun Kim | Environmental Engineering | Best Researcher Award

Associate Professor | Sunchon National University, South korea

Dr. Do Gun Kim is an accomplished environmental engineer and Associate Professor at Sunchon National University, Republic of Korea. With over two decades of academic, research, and industry experience, his expertise spans advanced water, wastewater, and groundwater treatment technologies. Dr. Kim began his career in the private sector with Kavotech and Ssangyong Engineering before transitioning to academia, holding key positions at JEI University and Kyung Hee University. He earned his B.S. from the University of Seoul and both his M.S. and Ph.D. from KAIST in Environmental Engineering. Dr. Kim has published extensively, with over 80 peer-reviewed articles and multiple patents to his name. His research emphasizes physico-chemical treatment processes, innovative materials for pollution remediation, and non-point source pollution management. He is recognized for blending theoretical knowledge with practical applications to address environmental challenges in water quality and sustainable engineering.

Profile

🎓 Education

Dr. Kim holds a Ph.D. in Environmental Engineering from Korea Advanced Institute of Science and Technology (KAIST), completed in August 2010, where his research focused on advanced water treatment technologies. Prior to his doctorate, he earned a Master of Science degree in Environmental Engineering from KAIST in February 1996, where he developed his foundation in physico-chemical treatment processes. His academic journey began with a Bachelor of Science in Environmental Engineering from the University of Seoul, which he completed in February 1993. Throughout his educational career, Dr. Kim has demonstrated a consistent commitment to addressing complex environmental challenges, particularly in the areas of pollution control and sustainable resource management. His academic background is further strengthened by two national engineering licenses in water pollution control and noise and vibration mitigation, awarded by the Human Resources Development Service of Korea. These qualifications support his applied and interdisciplinary approach to environmental research and teaching.

🧪 Experience

Dr. Do Gun Kim is currently an Associate Professor in the Department of Environmental Engineering at Sunchon National University since July 2020. Before this, he served as a Research Professor and Postdoctoral Researcher at Kyung Hee University (2010–2020), contributing to advanced civil and environmental engineering research. He also briefly worked as an Assistant Professor at JEI University in 2016, teaching environment and health courses. Dr. Kim’s professional experience includes significant time in the private sector with companies like SIB Co., Ltd. (2009–2010), Kavotech Co., Ltd. (2003–2008), and Ssangyong Engineering & Construction Co., Ltd. (until 2002), where he worked in R&D on environmental technologies. His well-rounded background bridges both academia and industry, providing him with practical insight into environmental systems, engineering design, and pollution control. These roles have shaped his approach to research, integrating laboratory innovation with real-world environmental problem-solving.

🏅 Awards and Honors

Dr. Do Gun Kim’s academic and research excellence is reflected in his extensive publication record, with 67 international and 14 domestic journal articles, alongside 7 Korean patents and 1 PCT international patent. His innovative work in environmental engineering has contributed significantly to the advancement of water treatment technologies and pollution reduction strategies. He holds two national-level professional engineering certifications—one in water pollution technology and another in noise and vibration—issued by the Human Resources Development Service of Korea. These certifications validate his technical expertise and professional contributions to environmental management. While specific named awards are not listed, Dr. Kim’s sustained funding, prolific publications, and patents underscore his recognition and impact in the field. His roles at top Korean institutions such as KAIST, Kyung Hee University, and Sunchon National University reflect the esteem in which he is held by academic and professional communities.

🔬 Research Focus

Dr. Kim’s research is centered on advanced physico-chemical processes for water, wastewater, and groundwater treatment. He focuses on key mechanisms like adsorption, catalysis, coagulation, filtration, and advanced oxidation processes to enhance contaminant removal efficiency. His work places strong emphasis on innovative materials, including carbon-based adsorbents, nano-metallic particles, and hybrid composites tailored for environmental remediation. Additionally, Dr. Kim actively investigates methods for reducing non-point source pollution, which poses significant challenges in urban and agricultural runoff management. His integrated approach combines theoretical modeling, lab-scale experimentation, and pilot-scale application. Through interdisciplinary collaboration, he aims to develop sustainable, cost-effective, and scalable solutions for improving water quality and environmental health. His projects often explore synergies between material science, environmental chemistry, and civil engineering, thereby pushing the boundaries of traditional water treatment paradigms. This multi-dimensional focus enhances resilience and sustainability in water resource management systems.

✅ Conclusion

Dr. Do Gun Kim is a dedicated environmental engineer whose multifaceted career integrates academic research, industry experience, and innovative water treatment solutions, making him a leading figure in sustainable environmental technologies.

Publications